Intellia Therapeutics ^Investors

Intellia Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2014 The company specializes in developing innovative gene-editing therapies using CRISPR technology to address various genetic diseases Intellia has raised a total of $108 million in funding to support its research and development efforts With a strong focus on advancing its therapeutic pipeline, Intellia aims to transform the treatment landscape for patients with serious genetic disorders The company is committed to scientific excellence and collaboration within the biotechnology community